A problem of patents
While Indian drug firms eye lucrative international markets, health agencies have their eye on those companies as a possible means of getting expensive new drugs to the poor. Many of the most
Related Content
- Towards an integral approach to sustainable agriculture and healthy nutrition
- Misguided research
- Genetic engineering enforces corporate control of agriculture
- Mashelkar Report on IP Rights Version II: Wrong again
- Innovation and technology transfer to address climate change
- No hair-raising experience this